High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$14.9M
$14,941,480
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
IONS
M
IONIS PHARMACEUTICALS INC
Jenne Kyle
• Officer • EVP, Chf GL Pdt Str Ofcr
Other
2026-03-10
$1,665,128Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf GL Pdt Str Ofcr
Other
|
2026-03-10 | $1,665,128Largex2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Jenne Kyle
• Officer • EVP, Chf GL Pdt Str Ofcr
10b5-1 SellΔOwn -43.2%
2026-03-10
$2,827,325Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf GL Pdt Str Ofcr
10b5-1 SellΔOwn -43.2%
|
2026-03-10 | $2,827,325Largex2 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Other
|
2026-03-10 | $2,076,532Large | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-10 | $2,589,144Largex2 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Other
|
2026-03-09 | $6,962,832Whalex2 | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-09 | $9,525,011Whalex3 | S | Form 4 |